Cargando…
Medical management of victims contaminated with radionuclides after a “dirty bomb” attack
A wide spectrum of scenarios may lead to radiation incidents and the liberation of radioactive material. In the case of a terrorist attack by a “dirty bomb”, there is a risk of mechanical and thermal trauma, external irradiation, superficial contamination and incorporation of radioactive material. T...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080556/ https://www.ncbi.nlm.nih.gov/pubmed/30086798 http://dx.doi.org/10.1186/s40779-018-0174-5 |
_version_ | 1783345501235576832 |
---|---|
author | Rump, Alexis Becker, Benjamin Eder, Stefan Lamkowski, Andreas Abend, Michael Port, Matthias |
author_facet | Rump, Alexis Becker, Benjamin Eder, Stefan Lamkowski, Andreas Abend, Michael Port, Matthias |
author_sort | Rump, Alexis |
collection | PubMed |
description | A wide spectrum of scenarios may lead to radiation incidents and the liberation of radioactive material. In the case of a terrorist attack by a “dirty bomb”, there is a risk of mechanical and thermal trauma, external irradiation, superficial contamination and incorporation of radioactive material. The first treatment priority must be given to the care of trauma patients with life-threatening injuries, as the health effects of radiation occur with latency. Radionuclide incorporation will lead to a longer-lasting irradiation from inside the body, associated with a higher risk of stochastic radiation effects (e.g., occurrence of tumors) in the long run. It must be expected that victims with potentially incorporated radionuclides will far outnumber trauma patients. The elimination of radionuclides can be enhanced by the administration of decorporation agents such as (Ca) Diethylenetriaminepentaacetic acid (DTPA) or Prussian blue, reducing the radiological burden of the body. There is still no consensus whether decorporation treatment should be started immediately based only on a suspicion of radionuclide incorporation (“urgent approach”) or if the results of internal dosimetry confirming the necessity of a treatment should be awaited, accepting the delay caused by the measurements and computations (“precautionary approach”). As the therapeutic effectiveness may be substantially decreased if treatment initiation is delayed only by several days, depending on the radionuclide, the physicochemical properties of the compounds involved and the route of absorption, we favor an “urgent approach” from a medical point of view. In doubt, it seems justified to treat victims by precaution, as the adverse effects of the medication seem minimal. However, in the case of a high number of victims, an “urgent treatment approach” may require a large number of daily doses of antidotes, and therefore, adequate investments in preparedness and antidote stockpiling are necessary. |
format | Online Article Text |
id | pubmed-6080556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60805562018-08-09 Medical management of victims contaminated with radionuclides after a “dirty bomb” attack Rump, Alexis Becker, Benjamin Eder, Stefan Lamkowski, Andreas Abend, Michael Port, Matthias Mil Med Res Perspective A wide spectrum of scenarios may lead to radiation incidents and the liberation of radioactive material. In the case of a terrorist attack by a “dirty bomb”, there is a risk of mechanical and thermal trauma, external irradiation, superficial contamination and incorporation of radioactive material. The first treatment priority must be given to the care of trauma patients with life-threatening injuries, as the health effects of radiation occur with latency. Radionuclide incorporation will lead to a longer-lasting irradiation from inside the body, associated with a higher risk of stochastic radiation effects (e.g., occurrence of tumors) in the long run. It must be expected that victims with potentially incorporated radionuclides will far outnumber trauma patients. The elimination of radionuclides can be enhanced by the administration of decorporation agents such as (Ca) Diethylenetriaminepentaacetic acid (DTPA) or Prussian blue, reducing the radiological burden of the body. There is still no consensus whether decorporation treatment should be started immediately based only on a suspicion of radionuclide incorporation (“urgent approach”) or if the results of internal dosimetry confirming the necessity of a treatment should be awaited, accepting the delay caused by the measurements and computations (“precautionary approach”). As the therapeutic effectiveness may be substantially decreased if treatment initiation is delayed only by several days, depending on the radionuclide, the physicochemical properties of the compounds involved and the route of absorption, we favor an “urgent approach” from a medical point of view. In doubt, it seems justified to treat victims by precaution, as the adverse effects of the medication seem minimal. However, in the case of a high number of victims, an “urgent treatment approach” may require a large number of daily doses of antidotes, and therefore, adequate investments in preparedness and antidote stockpiling are necessary. BioMed Central 2018-08-06 /pmc/articles/PMC6080556/ /pubmed/30086798 http://dx.doi.org/10.1186/s40779-018-0174-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Perspective Rump, Alexis Becker, Benjamin Eder, Stefan Lamkowski, Andreas Abend, Michael Port, Matthias Medical management of victims contaminated with radionuclides after a “dirty bomb” attack |
title | Medical management of victims contaminated with radionuclides after a “dirty bomb” attack |
title_full | Medical management of victims contaminated with radionuclides after a “dirty bomb” attack |
title_fullStr | Medical management of victims contaminated with radionuclides after a “dirty bomb” attack |
title_full_unstemmed | Medical management of victims contaminated with radionuclides after a “dirty bomb” attack |
title_short | Medical management of victims contaminated with radionuclides after a “dirty bomb” attack |
title_sort | medical management of victims contaminated with radionuclides after a “dirty bomb” attack |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080556/ https://www.ncbi.nlm.nih.gov/pubmed/30086798 http://dx.doi.org/10.1186/s40779-018-0174-5 |
work_keys_str_mv | AT rumpalexis medicalmanagementofvictimscontaminatedwithradionuclidesafteradirtybombattack AT beckerbenjamin medicalmanagementofvictimscontaminatedwithradionuclidesafteradirtybombattack AT ederstefan medicalmanagementofvictimscontaminatedwithradionuclidesafteradirtybombattack AT lamkowskiandreas medicalmanagementofvictimscontaminatedwithradionuclidesafteradirtybombattack AT abendmichael medicalmanagementofvictimscontaminatedwithradionuclidesafteradirtybombattack AT portmatthias medicalmanagementofvictimscontaminatedwithradionuclidesafteradirtybombattack |